NCOG-05. TIME TO FUNCTIONAL AND COGNITIVE DECLINE IN A PHASE 3 TRIAL OF TUMOR TREATING FIELDS WITH TEMOZOLOMIDE VERSUS TEMOZOLOMIDE ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Nicholas, Garth A
  • Hirte, Holger
  • Easaw, Jacob
  • Muanza, Thierry
  • Roberge, David
  • Mathieu, David
  • Pitz, Marshall

publication date

  • November 6, 2017